Genix Pharmaceuticals Corp (GENX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
| 07-2015 | 04-2015 | 01-2015 | 10-2014 | 07-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 283 | 462 | 282 | 362 | 529 |
| Receivables | 94 | 69 | 63 | 107 | 43 |
| Inventories | 91 | 64 | 101 | 118 | 124 |
| Other current assets | 0 | 0 | 0 | 13 | 0 |
| TOTAL | $468 | $595 | $446 | $603 | $733 |
| Non-Current Assets | |||||
| PPE Net | 205 | 202 | 224 | 179 | 1 |
| TOTAL | $205 | $202 | $224 | $179 | $1 |
| Total Assets | $673 | $797 | $670 | $782 | $734 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 63 | 21 | 30 | 37 | 51 |
| Accrued Expenses | 8 | 10 | 17 | 17 | N/A |
| TOTAL | $71 | $35 | $47 | $123 | $65 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 0 | 0 | 0 | 66 | 14 |
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $71 | $35 | $47 | $123 | $65 |
| Shareholders' Equity | |||||
| Retained earnings | -3,752 | -3,557 | -3,411 | -3,270 | -3,278 |
| Other shareholders' equity | 161 | 126 | 142 | 36 | 55 |
| TOTAL | $602 | $762 | $623 | $659 | $669 |
| Total Liabilities And Equity | $673 | $797 | $670 | $782 | $734 |